Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts
Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson S.A., to Medifarma, a pharmaceutical company based in Peru with a strong footprint in Latin America. The divestment aligns with Fresenius Kabi’s ongoing strategy to streamline its global production network […]